跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Moxeth-125
Approved
STANDARD
Moxeth-125
Sapphire Lifesciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b4050e9037e2ad2a
Company
Sapphire Lifesciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
b4050e9037e2ad2a
Drug Approval Philippines Name
Moxeth-125
Product Name
Moxeth-125
Registration Number
DRP-6699-01
Brand Name
Moxeth-125
Generic Name
Amoxicillin (As Trihydrate)
Dosage Form
Powder For Oral Suspension
Dosage Strength
125mg/5mL
Manufacturer
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Distributor
777 Red Pharma Inc.
Issuance Date
29 April 2021
Expiry Date
18 May 2026
Pharmacologic Category
Antibacterial (Penicillin)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b4050e9037e2ad2a
Type
Standard
Back to Philippines FDA Approvals
Moxeth-125 - Philippines FDA Drug Approval Details